Rankings
▼
Calendar
NAGE Q2 2018 Earnings — Niagen Bioscience Inc Revenue & Financial Results | Market Cap Arena
NAGE
Niagen Bioscience Inc
$393M
Q2 2018 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$8M
+85.0% YoY
Gross Profit
$4M
49.3% margin
Operating Income
-$8M
-101.7% margin
Net Income
-$8M
-103.2% margin
EPS (Diluted)
$-0.15
QoQ Revenue Growth
+18.8%
Cash Flow
Operating Cash Flow
-$7M
Free Cash Flow
-$8M
Stock-Based Comp.
$2M
Balance Sheet
Total Assets
$52M
Total Liabilities
$12M
Stockholders' Equity
$41M
Cash & Equivalents
$33M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$8M
$4M
+85.0%
Gross Profit
$4M
$2M
+82.4%
Operating Income
-$8M
-$3M
-199.5%
Net Income
-$8M
-$3M
-191.2%
← FY 2018
All Quarters
Q3 2018 →